Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+१.८४%
१,११५.०२
+२०.१८
+१.८४%
१,०९४.८४१,१०७.९११,११९.१११,१०७.९१
SIXC
Communications
SIXC
Communications
SIXC
+१.५६%
६१३.६१
+९.४०
+१.५६%
६०४.२१६०४.२१६१४.७३६०४.२१
SIXE
Energy
SIXE
Energy
SIXE
-३.८४%
१,२०१.७८
-४७.९३
-३.८४%
१,२४९.७११,२१९.४६१,२१९.४६१,१९१.६६
SIXI
Industrials
SIXI
Industrials
SIXI
+२.०८%
१,७७५.४२
+३६.१६
+२.०८%
१,७३९.२६१,७५४.१११,७८३.९६१,७५४.११
SIXM
Financials
SIXM
Financials
SIXM
+०.५९%
६३९.४१
+३.७८
+०.५९%
६३५.६३६३७.४६६४३.४२६३७.४६
SIXR
Staples
SIXR
Staples
SIXR
-०.०५%
८४७.८९
-०.४३
-०.०५%
८४८.३२८५०.९०८५३.०५८४६.६८
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+१.५७%
२२०.१७
+३.४१
+१.५७%
२१६.७६२१६.७६२२०.४०२१६.७६
SIXT
Technology
SIXT
Technology
SIXT
+१.५९%
३,३८८.२९
+५३.१५
+१.५९%
३,३३५.१४३,३७६.१३३,४०६.१२३,३६०.२९
SIXU
Utilities
SIXU
Utilities
SIXU
-१.१३%
९२८.७०
-१०.६४
-१.१३%
९३९.३४९३७.३२९३७.५९९२४.४८
SIXV
Health care
SIXV
Health care
SIXV
-०.१४%
१,४६६.१०
-२.०७
-०.१४%
१,४६८.१७१,४६८.९८१,४७६.५०१,४६५.३६
SIXY
Discretionary
SIXY
Discretionary
SIXY
+१.३५%
२,४१९.२३
+३२.१४
+१.३५%
२,३८७.०९२,३९४.१८२,४२१.७४२,३९४.१८
BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.०२५
+४.१७%
(+०.००१०) 1D
मे ६, १६:१०:१० GMT+१०  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for BOT...
Open
A$ ०.०२
High
A$ ०.०३
Low
A$ ०.०२
Mkt. cap
७.९१ करोड
Avg. vol.
३.०७ करोड
Volume
२.३६ करोड
52-wk high
A$ ०.४७
52-wk low
A$ ०.०२
EPS
-A$ ०.०५
Shares outstanding
२.७२ अरब
No. of employees
११
News stories
From sources across the web
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees११
Founded१९८४
Headquarters-
Sector-
Last report
२०२६ जनवरी २६
Fiscal Period
Q2 2026
Normalized EPS / Estimate
-/ -AUD
Revenue / Estimate
८२.५३ लाख/ (- est.)AUD
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
२७.०६ लाख
२७.०६ लाख
८२.५३ लाख
८२.५३ लाख
Cost of goods sold
१२.८१ लाख
१२.८१ लाख
२९.८० लाख
२९.८० लाख
Cost of revenue
१२.८१ लाख
१२.८१ लाख
२९.८० लाख
२९.८० लाख
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.१४ करोड
२.१४ करोड
१.८३ करोड
१.८३ करोड
Operating expense
२.६९ करोड
२.६९ करोड
२.२१ करोड
२.२१ करोड
Total operating expenses
२.८२ करोड
२.८२ करोड
२.५१ करोड
२.५१ करोड
Operating income
-२.५५ करोड
-२.५५ करोड
-१.६८ करोड
-१.६८ करोड
Other non operating income
-
-
६.८३ लाख
६.८३ लाख
EBT including unusual items
-२.७८ करोड
-२.७८ करोड
-१.६६ करोड
-१.६६ करोड
EBT excluding unusual items
-२.७८ करोड
-२.७८ करोड
-१.६६ करोड
-१.६६ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.७८ करोड
-२.७८ करोड
-१.६६ करोड
-१.६६ करोड
Net profit margin
-१,०२५.७३%
-१,०२५.७३%
-२०१.११%
-२०१.११%
Earnings per share
-
-
-
-
Interest and investment income
३.४७ लाख
३.४७ लाख
३.५३ लाख
३.५३ लाख
Interest expense
-२६.६६ लाख
-२६.६६ लाख
-८.०२ लाख
-८.०२ लाख
Net interest expenses
-२३.१९ लाख
-२३.१९ लाख
-४.५० लाख
-४.५० लाख
Depreciation and amortization charges
५.७३ लाख
५.७३ लाख
५.९३ लाख
५.९३ लाख
EBITDA
-२.४९ करोड
-२.४९ करोड
-१.६२ करोड
-१.६२ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more